$CLRI
Cleartronic, Inc.

2023 Q2 Form 10-Q Financial Statement

#000109181823000074 Filed on May 12, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q3
Revenue $560.4K $510.7K $489.7K
YoY Change 4.14% 8.51% 12.99%
Cost Of Revenue $80.71K $71.55K $86.06K
YoY Change -10.26% 8.57% 25.23%
Gross Profit $479.7K $439.1K $403.6K
YoY Change 7.03% 8.5% 10.68%
Gross Profit Margin 85.6% 85.99% 82.42%
Selling, General & Admin $468.4K $361.7K $272.6K
YoY Change 66.62% 44.1% 11.9%
% of Gross Profit 97.65% 82.37% 67.54%
Research & Development $2.000K $2.000K $61.72K
YoY Change -95.74% -95.75% 25.83%
% of Gross Profit 0.42% 0.46% 15.29%
Depreciation & Amortization $1.332K $1.282K $1.000K
YoY Change 38.89% 33.54% 40.85%
% of Gross Profit 0.28% 0.29% 0.25%
Operating Expenses $471.7K $365.0K $335.3K
YoY Change 43.38% 22.08% 14.3%
Operating Profit $7.934K $74.15K $68.30K
YoY Change -93.34% -29.88% -4.23%
Interest Expense $690.00 $680.00 -$130.00
YoY Change -630.77% -780.0% -51.85%
% of Operating Profit 8.7% 0.92% -0.19%
Other Income/Expense, Net $686.00 $678.00
YoY Change -98.56% -771.29%
Pretax Income $8.620K $74.83K $68.17K
YoY Change -94.83% -29.18% -63.99%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $8.620K $74.83K $57.83K
YoY Change -94.83% -29.18% -69.45%
Net Earnings / Revenue 1.54% 14.65% 11.81%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $96.47
COMMON SHARES
Basic Shares Outstanding 228.8M shares 228.8M shares 228.1M shares
Diluted Shares Outstanding 599.4M shares 599.5M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $426.5K $385.8K $468.2K
YoY Change 87.84% 0.51% 16.75%
Cash & Equivalents $426.5K $385.7K $468.2K
Short-Term Investments
Other Short-Term Assets $91.33K $33.62K $53.61K
YoY Change 241.68% -6.71% 13.15%
Inventory $20.43K $22.07K $21.10K
Prepaid Expenses $40.33K $20.87K $15.36K
Receivables $609.1K $531.0K $538.0K
Other Receivables $2.030K $1.350K $0.00
Total Short-Term Assets $1.149M $973.8K $1.081M
YoY Change 57.94% 33.42% 38.0%
LONG-TERM ASSETS
Property, Plant & Equipment $17.88K $17.10K $15.14K
YoY Change 30.38% 16.48% 32.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $107.1K $112.3K $68.44K
YoY Change 59.78% 65.19% 21.8%
TOTAL ASSETS
Total Short-Term Assets $1.149M $973.8K $1.081M
Total Long-Term Assets $107.1K $112.3K $68.44K
Total Assets $1.256M $1.086M $1.149M
YoY Change 58.09% 36.13% 36.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $87.16K $79.80K $75.22K
YoY Change -24.76% -47.85% -52.97%
Accrued Expenses $23.91K $23.24K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.112M $937.1K $1.087M
YoY Change 40.64% -0.29% -4.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $95.29K $108.4K $113.3K
YoY Change -22.9% -24.92% -26.67%
Total Long-Term Liabilities $95.29K $108.4K $113.3K
YoY Change -22.91% -24.93% -26.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.112M $937.1K $1.087M
Total Long-Term Liabilities $95.29K $108.4K $113.3K
Total Liabilities $1.207M $1.046M $1.201M
YoY Change 32.05% -3.57% -7.05%
SHAREHOLDERS EQUITY
Retained Earnings -$15.19M -$15.20M -$15.29M
YoY Change -1.1% -2.55%
Common Stock $2.289K $2.288K $2.281K
YoY Change 0.35% -0.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.15K $40.53K -$51.38K
YoY Change
Total Liabilities & Shareholders Equity $1.256M $1.086M $1.149M
YoY Change 58.09% 36.13% 36.91%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q3
OPERATING ACTIVITIES
Net Income $8.620K $74.83K $57.83K
YoY Change -94.83% -29.18% -69.45%
Depreciation, Depletion And Amortization $1.332K $1.282K $1.000K
YoY Change 38.89% 33.54% 40.85%
Cash From Operating Activities $42.87K $109.9K $243.6K
YoY Change -127.35% 1835.04% 138.94%
INVESTING ACTIVITIES
Capital Expenditures $2.120K $4.320K -$2.420K
YoY Change -19.87%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.120K -$4.320K -$2.420K
YoY Change -19.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 42.87K 109.9K 243.6K
Cash From Investing Activities -2.120K -4.320K -2.420K
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash 40.75K 105.6K 241.1K
YoY Change -126.0% 1758.98% 143.79%
FREE CASH FLOW
Cash From Operating Activities $42.87K $109.9K $243.6K
Capital Expenditures $2.120K $4.320K -$2.420K
Free Cash Flow $40.75K $105.6K $246.0K
YoY Change -126.0% 1758.98% 134.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
2011278 usd
CY2023Q1 us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
1017318 usd
CY2022 us-gaap Contract With Customer Asset Allowance For Credit Loss Writeoff
ContractWithCustomerAssetAllowanceForCreditLossWriteoff
2017563 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0958798
dei Entity Address Address Line1
EntityAddressAddressLine1
28050 US Hwy 19N
dei Entity Address City Or Town
EntityAddressCityOrTown
Clearwater
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33761
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Inventory Net
InventoryNet
22070 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
21097 usd
dei Security12b Title
Security12bTitle
Common stock Par Value $0.00001
dei Trading Symbol
TradingSymbol
CLRI
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
228780695 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
385747 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
468167 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
531024 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
538030 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33616 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53611 usd
CY2023Q1 clri Accounts Receivable Related Partie Current
AccountsReceivableRelatedPartieCurrent
1343 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
973800 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1080905 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17099 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15142 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41880 usd
CY2023Q1 clri Due From Related Partie
DueFromRelatedPartie
53302 usd
CY2022Q3 clri Due From Related Partie
DueFromRelatedPartie
53302 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
53302 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
53302 usd
CY2023Q1 us-gaap Assets
Assets
1086081 usd
CY2022Q3 us-gaap Assets
Assets
1149349 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
79801 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75217 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
834097 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1012211 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23244 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
937142 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1087428 usd
CY2023Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
89267 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
113300 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19138 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
108405 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
113300 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1045547 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1200728 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2288 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2281 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240106 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240112 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15201935 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15293848 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
40534 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1086081 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1149349 usd
CY2023Q1 us-gaap Revenues
Revenues
510668 usd
CY2022Q1 us-gaap Revenues
Revenues
470623 usd
us-gaap Revenues
Revenues
1017318 usd
us-gaap Revenues
Revenues
989808 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
71546 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
65900 usd
us-gaap Cost Of Revenue
CostOfRevenue
149037 usd
us-gaap Cost Of Revenue
CostOfRevenue
158136 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
439122 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
404723 usd
us-gaap Gross Profit
GrossProfit
868281 usd
us-gaap Gross Profit
GrossProfit
831672 usd
CY2023Q1 us-gaap Selling Expense
SellingExpense
66831 usd
CY2022Q1 us-gaap Selling Expense
SellingExpense
35003 usd
us-gaap Selling Expense
SellingExpense
134662 usd
us-gaap Selling Expense
SellingExpense
120532 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
294858 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
259910 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
616756 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
535418 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1282 usd
CY2022Q1 us-gaap Depreciation
Depreciation
960 usd
us-gaap Depreciation
Depreciation
2362 usd
us-gaap Depreciation
Depreciation
1774 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3093 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23815 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7776 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
364971 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
298966 usd
us-gaap Operating Expenses
OperatingExpenses
777595 usd
us-gaap Operating Expenses
OperatingExpenses
665500 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
678 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-101 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1227 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-269 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
678 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-101 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1227 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-269 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
74829 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
105656 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
91913 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
165903 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
74829 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
105656 usd
us-gaap Net Income Loss
NetIncomeLoss
91913 usd
us-gaap Net Income Loss
NetIncomeLoss
165903 usd
CY2023Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10119 usd
CY2022Q1 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10119 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
20463 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
20463 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64710 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
95537 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
71450 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
145440 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228780695 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228359918 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228704541 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228359918 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599721553 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599406176 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599721553 shares
us-gaap Net Income Loss
NetIncomeLoss
91913 usd
us-gaap Net Income Loss
NetIncomeLoss
165903 usd
us-gaap Depreciation
Depreciation
2362 usd
us-gaap Depreciation
Depreciation
1774 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5983 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7006 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29434 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
973 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4595 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-18652 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11343 usd
us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
8501 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4585 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6922 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-202147 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-200601 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5481 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-78100 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12165 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4320 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5058 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4320 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5058 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-82420 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-17223 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
468167 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401001 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
385747 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
383778 usd
us-gaap Interest Paid Net
InterestPaidNet
117 usd
us-gaap Interest Paid Net
InterestPaidNet
269 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
400 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
690 usd
clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
7 usd
clri Rightofuse Asset Obtained In Exchange For Operating Lease Liability
RightofuseAssetObtainedInExchangeForOperatingLeaseLiability
47863 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
us-gaap Net Income Loss
NetIncomeLoss
91913 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
40534 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-34295 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
74829 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
40534 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-452274 usd
us-gaap Net Income Loss
NetIncomeLoss
165903 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-286371 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-392027 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
105656 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-286371 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin:0pt"><b>USE OF ESTIMATES</b></p><p style="margin:0pt"> </p><p style="margin:0pt">In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period. <br/></p><p style="margin:0pt">Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. </p><p style="margin:0pt"> </p><p style="margin:0pt">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for doubtful accounts.</p><p style="margin:0pt"> </p>
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18000 usd
CY2023Q1 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
12750 usd
CY2022Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
38250 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
20866 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15361 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin:0pt"><b>CONCENTRATION OF CREDIT RISK </b></p><p style="margin:0pt"> </p><p style="margin:0pt">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $250,000 at all FDIC-insured institutions. As of March 31, 2023 and September 30, 2022, the Company had $128,346 and $208,135, respectively, in excess of FDIC insurance limits.</p><p style="margin:0pt"> </p>
CY2023Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
128346 usd
CY2022 clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
208135 usd
CY2023Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
2000 usd
CY2022Q1 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
47016 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
23815 usd
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
96276 usd
CY2023Q1 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
12750 usd
CY2022Q3 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
38250 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
923364 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
1125511 usd
CY2023Q1 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
510668 usd
CY2022Q1 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
470623 usd
us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
1017318 usd
us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
989808 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125511 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1131796 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
815171 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
923364 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125511 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64710 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
95537 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228780695 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228359918 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
71450 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
145440 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228704541 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228359918 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
64710 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
95537 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10119 usd
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10119 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
74829 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
105656 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228780695 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228359918 shares
CY2023Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370701635 shares
CY2022Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
371361635 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599482330 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599721553 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
71450 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
145440 usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
20463 usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
20463 usd
us-gaap Net Income Loss
NetIncomeLoss
91913 usd
us-gaap Net Income Loss
NetIncomeLoss
165903 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228704541 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228359918 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370701635 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
371361635 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599406176 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599721553 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
22070 usd
CY2023Q1 us-gaap Other Inventory
OtherInventory
0 usd
CY2022Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
21097 usd
CY2022Q3 us-gaap Other Inventory
OtherInventory
0 usd
CY2023Q1 us-gaap Advertising Expense
AdvertisingExpense
17618 usd
CY2022Q1 us-gaap Advertising Expense
AdvertisingExpense
6796 usd
us-gaap Advertising Expense
AdvertisingExpense
30767 usd
us-gaap Advertising Expense
AdvertisingExpense
11821 usd
CY2023Q1 us-gaap Area Of Land
AreaOfLand
1145 sqm
us-gaap Payments For Rent
PaymentsForRent
2134 usd
us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
2198 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41880 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
42382 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08 pure
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5983 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
921 usd
us-gaap Lease Cost
LeaseCost
6904 usd
us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
6402 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
47863 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12804 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
26184 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6594 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
45582 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3200 usd
CY2023Q1 clri Present Value Of Operating Lease Liability
PresentValueOfOperatingLeaseLiability
42382 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
23244 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
19138 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25925 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21605 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8826 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6463 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17099 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15142 usd
CY2023Q1 us-gaap Depreciation
Depreciation
1282 usd
CY2022Q1 us-gaap Depreciation
Depreciation
960 usd
us-gaap Depreciation
Depreciation
2362 usd
us-gaap Depreciation
Depreciation
1774 usd
CY2023Q1 us-gaap Cumulative Dividends
CumulativeDividends
185606 usd
CY2022Q3 us-gaap Cumulative Dividends
CumulativeDividends
165035 usd
CY2022Q4 us-gaap Temporary Equity Description
TemporaryEquityDescription
There are currently 5 series of preferred stock designated as follows:   ● 1,250,000 shares have been designated as Series A Preferred Stock, 512,996 of which are issued and outstanding;   ● 10 shares have been designated as Series B Preferred Stock, none of which is issued and outstanding;   ● 50,000,000 shares have been designated as Series C Preferred Stock, 3,209,503 of which are issued and outstanding; and   ● 10,000,000 shares have been designated Series D Preferred stock, of which 670,904 are issued and outstanding; and   ● 10,000,000 shares have been designated Series E Preferred stock, of which 3,000,000 are issued and outstanding.
clri Number Of Common Stock Shares Issued From Conversion Of Series C Preferred Stock Converted
NumberOfCommonStockSharesIssuedFromConversionOfSeriesCPreferredStockConverted
660000 shares
CY2022Q4 clri Advanced Amounts
AdvancedAmounts
53302 usd
CY2022Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
1145 sqm
CY2022Q4 clri Monthly Rental Cost
MonthlyRentalCost
2134 usd
CY2022Q4 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2198 usd
CY2021Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
2000 sqft
CY2021Q4 clri Monthly Rental Cost
MonthlyRentalCost
2200 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-11-30
clri Concentration Risk The Hold Percentage
ConcentrationRiskTheHoldPercentage
0.17 pure
clri Concentration Risk Percentage
ConcentrationRiskPercentage
0.10 pure
CY2022 clri Concentration Risk Percentage
ConcentrationRiskPercentage
0.10 pure
us-gaap Royalty Expense
RoyaltyExpense
5640 usd
us-gaap Royalty Expense
RoyaltyExpense
4000 usd
dei Entity Registrant Name
EntityRegistrantName
Cleartronic, Inc.
dei Local Phone Number
LocalPhoneNumber
289-7620
dei City Area Code
CityAreaCode
813
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228120695 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228120695 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228780695 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228780695 shares
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
usd
clri Rightofuse Asset Obtained In Exchange For Operating Lease Liability
RightofuseAssetObtainedInExchangeForOperatingLeaseLiability
usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
usd
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
pure
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
usd
CY2022 us-gaap Lease Cost
LeaseCost
usd
CY2022 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001362516
dei Entity File Number
EntityFileNumber
000-55329

Files In Submission

Name View Source Status
clri-20230331_pre.xml Edgar Link unprocessable
0001091818-23-000074-index-headers.html Edgar Link pending
0001091818-23-000074-index.html Edgar Link pending
0001091818-23-000074.txt Edgar Link pending
0001091818-23-000074-xbrl.zip Edgar Link pending
clri-20230331.htm Edgar Link pending
clri-20230331.xsd Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
clri-20230331_cal.xml Edgar Link unprocessable
clri-20230331_def.xml Edgar Link unprocessable
clri-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clri-20230331_htm.xml Edgar Link completed
report.css Edgar Link pending
Show.js Edgar Link pending